Elite Pharmaceuticals Inc (ELTP)

[Couch]

The PPS on the OTC rarely corresponds to the real value of the company as with ELTP. And it is clear that when Elite markets it's fist ART product I will look back in hindsight knowing that the company was/is highly undervalued currently. I've already listed the highlights - as in positives. Just look the sticky note.

Again, the only negative that I can put my finger on was the uncertainty of the efficacy trial. But hey I'll return the request. Please list how the CC was negative and specifically in relation to Nasrat? I've been on every call for the past three plus years. The removal of the ongoing concern speaks volumes.

IMO the drop in PPS has zero to do with the value of the company.